- decreased bone mineral density / IMPC
- decreased circulating calcium level / IMPC
- abnormal cranium morphology / IMPC
- abnormal maxilla morphology / IMPC
- decreased body length / IMPC
- decreased body weight / IMPC
- decreased caudal vertebrae number / IMPC
- increased circulating HDL cholesterol level / IMPC
- increased mean platelet volume / IMPC
- decreased heart weight / IMPC
- decreased circulating alkaline phosphatase level / IMPC
- increased circulating glycerol level / IMPC
- abnormal bone structure / IMPC
- decreased lean body mass / IMPC
- increased circulating creatinine level / IMPC
- decreased circulating total protein level / IMPC
- decreased NK cell number / IMPC
- increased circulating iron level / IMPC
- decreased total body fat amount / IMPC
- decreased bone mineral content / IMPC
B6Brd;B6N-Tyrc-Brd Slc38a10tm1a(EUCOMM)Wtsi/WtsiCnbc
Status | Available to order |
EMMA ID | EM:05087 |
International strain name | B6Brd;B6N-Tyrc-Brd Slc38a10tm1a(EUCOMM)Wtsi/WtsiCnbc |
Alternative name | EPD0058_1_A04 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Slc38a10tm1a(EUCOMM)Wtsi, |
Gene/Transgene symbol | Slc38a10 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0058_1_A04. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | CNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain |
Disease and phenotype information
IMPC phenotypes (allele matching)
MGI phenotypes (allele matching)
- fragile skeleton / MGI
- decreased bone mineral density / MGI
- abnormal liver physiology / MGI
- decreased body length / MGI
- decreased body weight / MGI
- decreased lean body mass / MGI
- decreased length of long bones / MGI
- increased energy expenditure / MGI
- increased oxygen consumption / MGI
- decreased circulating serum albumin level / MGI
- increased circulating creatinine level / MGI
- decreased circulating amylase level / MGI
- decreased total body fat amount / MGI
- decreased bone mineral content / MGI
- decreased circulating calcium level / MGI
- abnormal cranium morphology / MGI
- abnormal maxilla morphology / MGI
- decreased hemoglobin content / MGI
- decreased erythrocyte cell number / MGI
- decreased circulating alkaline phosphatase level / MGI
- decreased circulating total protein level / MGI
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).